Add BrightSurf on Google Email

Cognitive behavioral therapy and medication is effective in the treatment of panic disorder

A randomized controlled trial found that combining cognitive-behavioral therapy (CBT) with medication significantly improved treatment outcomes for patients with panic disorder. Patients receiving CBT and medication had higher remission rates and greater improvements in mental health functioning compared to those receiving usual care.

SourceJAMA Network·JournalArchives of General Psychiatry·DateMar 7, 2005

Mental health symptoms common at Pentagon after 9/11

A study of Pentagon personnel found that nearly 21 percent experienced mental health symptoms, including generalized anxiety and depression, following the 9/11 attacks. The researchers also discovered that a significant portion of those at high risk for mental health problems sought counseling after the attack.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateApr 16, 2004

Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds

A new study suggests that propranolol can reduce the incidence of post-traumatic stress disorder (PTSD) in trauma victims if administered promptly. The medication, commonly used to treat anxiety and high blood pressure, was found to decrease PTSD symptoms by half compared to those who did not receive it.

SourceUniversity of California - San Francisco·JournalBiological Psychiatry·DateOct 22, 2003

Discovery that common mood disorders are inherited together may reveal genetic underpinnings

Scientists at Johns Hopkins Medicine found that panic disorder and manic depressive (bipolar) illness are likely related genetically and share a common cause. The study analyzed 203 families with bipolar disorder and identified symptoms of major mood disorders in relatives, showing a strong genetic link between the conditions.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Psychiatry·DateJan 9, 2002

A Genetic Marker Of Panic Disorder

Researchers identify a genetic marker associated with panic disorder, linked to variations in cholecystokinin (CCK) receptor function. The study found that this variation could be a risk factor for panic attacks and may be useful in diagnosis and therapeutic approaches.

SourceMolecular Psychiatry·JournalMolecular Psychiatry·DateMay 28, 1999